Single-cell spatial landscapes of the lung tumour immune microenvironment

M Sorin, M Rezanejad, E Karimi, B Fiset, L Desharnais… - Nature, 2023 - nature.com
Single-cell technologies have revealed the complexity of the tumour immune
microenvironment with unparalleled resolution,,,,,,,–. Most clinical strategies rely on …

Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies

Y Xu, W Li, S Lin, B Liu, P Wu, L Li - Cell Communication and Signaling, 2023 - Springer
Abstract Cancer-associated fibroblasts (CAFs), enriched in the tumor stroma, have received
increasing attention because of their multifaceted effects on tumorigenesis, development …

Spatial analysis by current multiplexed imaging technologies for the molecular characterisation of cancer tissues

T Semba, T Ishimoto - British Journal of Cancer, 2024 - nature.com
Tumours are composed of tumour cells and the surrounding tumour microenvironment
(TME), and the molecular characterisation of the various elements of the TME and their …

Potential crosstalk between SPP1+ TAMs and CD8+ exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer

Y Du, Y Lin, L Gan, S Wang, S Chen, C Li… - Journal of Translational …, 2024 - Springer
Background Immunotherapy brings new hope to patients with advanced gastric cancer.
However, liver metastases can reduce the efficacy of immunotherapy in patients. Tumor …

CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage

R Wei, J Song, H Pan, X Liu, J Gao - Oncoimmunology, 2024 - Taylor & Francis
Cancer-associated fibroblasts (CAFs) exhibit remarkable phenotypic heterogeneity, with
specific subsets implicated in immunosuppression in various malignancies. However …

Comprehensive molecular phenoty** of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities

C Xu, KK Huang, JH Law, JS Chua, T Sheng… - Gut, 2023 - gut.bmj.com
Objective Gastric cancer (GC) is a leading cause of cancer mortality, with ARID1A being the
second most frequently mutated driver gene in GC. We sought to decipher ARID1A-specific …

[HTML][HTML] Comprehensive integration of single-cell RNA and transcriptome RNA sequencing to establish a pyroptosis-related signature for improving prognostic …

J Li, T Yu, J Sun, M Ma, Z Zheng, W Kang… - Computational and …, 2024 - Elsevier
Cell pyroptosis, a Gasdermin-dependent programmed cell death characterized by
inflammasome, plays a complex and dynamic role in Gastric cancer (GC), a serious threat to …

[HTML][HTML] Non-coding RNAs: foes or friends for targeting tumor microenvironment

A Szymanowska, C Rodriguez-Aguayo… - Non-coding RNA, 2023 - mdpi.com
Non-coding RNAs (ncRNAs) are a group of molecules critical for cell development and
growth regulation. They are key regulators of important cellular pathways in the tumor …

Advancing gastric cancer treatment: Nanotechnology innovations and future prospects

T Yang, L Guo - Cell Biology and Toxicology, 2024 - Springer
Gastric cancer (GC) is the fifth most common cancer worldwide, particularly prevalent in
Asia, especially in China, where both its incidence and mortality rates are significantly high …

Identification and validation of a metabolism-related prognostic signature associated with M2 macrophage infiltration in gastric cancer

Y Liu, H Zheng, AM Gu, Y Li, T Wang, C Li… - International Journal of …, 2023 - mdpi.com
High levels of M2 macrophage infiltration invariably contribute to poor cancer prognosis and
can be manipulated by metabolic reprogramming in the tumor microenvironment. However …